Chemical screens provide a valuable approach for identifying small molecules that can regulate embryogenesis and control biological processes. With the identification of chemical compounds from specific assays, it is possible to define the temporal inductive events that establish embryonic differentiation pathways. Furthermore, an advantage of chemical screens over genetic screens includes the identification of molecules that may possess the ability to function in multiple organisms. Whole organism chemical screens also allow for rapid validation of chemical compounds by eliminating toxic and non-specific compounds often found in high-throughput screening.
The Aims outlined in this proposal combine experimental embryology, molecular biology, and high throughput screening technology to identify chemical compounds that influence the earliest molecular events regulating zebrafish development. Model organisms have long served as a tool for drug discovery, but whole organism screens have not yet found wide application in high-throughput chemical genetics applications. This has been partly because of the relatively greater amounts of compounds required for organisms and the laborious nature of assaying compound effect, which is typically done by visual observation. Nonetheless, because of the growing interest in systems biology and the recognition of the complexities of biological pathways, there is increasing enthusiasm for exploiting organism-based phenotypic assays in an high throughput screening format. In this application, we propose to leverage the strengths and resources of our existing zebrafish and drug discovery programs at the University of Pittsburgh to develop and implement tools and procedures for conducting chemical screens in zebrafish. The drug discovery center has extensive high throughput screening capabilities, including multimode plate readers, an ArrayScanll automated image acquisition and analysis instrument, and automated liquid handlers. The chemical compounds we identify from the assays outlined in this proposal, and the screen technology we adapt to zebrafish research will become important tools for the scientific community.
|Chiba, Takuto; Skrypnyk, Nataliya I; Skvarca, Lauren Brilli et al. (2016) Retinoic Acid Signaling Coordinates Macrophage-Dependent Injury and Repair after AKI. J Am Soc Nephrol 27:495-508|
|Chiba, Takuto; Hukriede, Neil; de Caestecker, Mark P (2015) Kidney Regeneration: Lessons from Development. Curr Pathobiol Rep 3:67-79|
|Skrypnyk, Nataliya I; Sanker, Subramaniam; Brilli-Skvarca, Lauren et al. (2015) Delayed treatment with PTBA analogs reduces post injury renal fibrosis after kidney injury. Am J Physiol Renal Physiol :ajprenal.00503.2015|
|Cirio, M Cecilia; de Groh, Eric D; de Caestecker, Mark P et al. (2014) Kidney regeneration: common themes from the embryo to the adult. Pediatr Nephrol 29:553-64|
|Korotchenko, Vasiliy N; Saydmohammed, Manush; Vollmer, Laura L et al. (2014) In vivo structure-activity relationship studies support allosteric targeting of a dual specificity phosphatase. Chembiochem 15:1436-45|
|Tomar, Ritu; Mudumana, Sudha P; Pathak, Narendra et al. (2014) osr1 is required for podocyte development downstream of wt1a. J Am Soc Nephrol 25:2539-45|
|Novitskaya, Tatiana; McDermott, Lee; Zhang, Ke Xin et al. (2014) A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury. Am J Physiol Renal Physiol 306:F496-504|
|Brilli, Lauren L; Swanhart, Lisa M; de Caestecker, Mark P et al. (2013) HDAC inhibitors in kidney development and disease. Pediatr Nephrol 28:1909-21|
|Sanker, Subramaniam; Cirio, Maria Cecilia; Vollmer, Laura L et al. (2013) Development of high-content assays for kidney progenitor cell expansion in transgenic zebrafish. J Biomol Screen 18:1193-202|
|Cianciolo Cosentino, Chiara; Skrypnyk, Nataliya I; Brilli, Lauren L et al. (2013) Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol 24:943-53|
Showing the most recent 10 out of 26 publications